Order Article Reprints

Corbeau A, Nout RA, Mens JWM, Horeweg N, Godart J, Kerkhof EM, Kuipers SC, van Poelgeest MIE, Kroep JR, Boere IA, et al. PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System. Cancers. 2021; 13(20):5179. https://doi.org/10.3390/cancers13205179

Corbeau, Anouk, Remi A. Nout, Jan Willem M. Mens, Nanda Horeweg, Jérémy Godart, Ellen M. Kerkhof, Sander C. Kuipers, Mariette I. E. van Poelgeest, Judith R. Kroep, Ingrid A. Boere, and et al. 2021. "PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System" Cancers 13, no. 20: 5179. https://doi.org/10.3390/cancers13205179

Corbeau, A., Nout, R. A., Mens, J. W. M., Horeweg, N., Godart, J., Kerkhof, E. M., Kuipers, S. C., van Poelgeest, M. I. E., Kroep, J. R., Boere, I. A., van Doorn, H. C., Hoogeman, M. S., van der Heide, U. A., Putter, H., Welters, M. J. P., van der Burg, S. H., Creutzberg, C. L., & de Boer, S. M. (2021). PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System. Cancers, 13(20), 5179. https://doi.org/10.3390/cancers13205179